Insider Shareholders with Direct Ownership of Sonnet Bio Therapeutics Holdings, Inc. (SONN)
This section provides a comprehensive overview of the insiders with direct ownership of Sonnet Bio Therapeutics Holdings, Inc. (SONN). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Sonnet BioTherapeutics Holdings, Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Raghu Rao
Interim CEO |
53,920 | 0 | 22,356 $101,272 | 5 |
Jul 11, 2025
Added 47.22%
|
|
Pankaj Mohan
Chairman, President and CEO |
973,430 | 73,561 | 14,987 $67,891 | 9 |
Dec 11, 2023
Added 33.51%
|
|
John K. Cini
Chief Scientific Officer |
131,024 | 32,555 | 14,116 $63,945 | 7 |
Jul 11, 2025
Added 45.95%
|
|
Nailesh Bhatt
Director |
53,295 | 0 | 10,547 $47,777 | 5 |
Jul 11, 2025
Added 48.67%
|
|
Donald J. Griffith
Chief Financial Officer |
28,531 | 9,239 | 10,375 $46,998 | 7 |
Jul 11, 2025
Added 49.08%
|
|
Susan Dexter
Chief Technical Officer |
111,810 | 24,772 | 9,643 $43,682 | 8 |
Jul 11, 2025
Added 45.34%
|
|
Richard T Kenney
Chief Medical Officer |
88,525 | 14,627 | 9,374 $42,464 | 8 |
Jul 11, 2025
Added 46.05%
|
|
Stephen J Mcandrew
Chief Business Officer |
6,000 | 0 | 6,446 $29,200 | 1 |
Jul 11, 2025
Added 48.21%
|
|
Lori Mc Neill
Director |
8,143 | 0 | 4,394 $19,904 | 3 |
Jul 11, 2025
Added 47.65%
|
|
John Harry Cross Iii
Chief Financial Officer |
82,470 | 3,412 | 1,588 $7,193 | 4 |
Dec 11, 2023
Reduced 47.76%
|
|
Albert D. Dyrness
Director |
45,550 | 0 | 537 $2,432 | 5 |
Dec 11, 2023
Added 40.99%
|